Monday, January 14, 2019
CVS Health headwind concerns overblown, says Cowen
Cowen analyst Charles Ryhee updated his model on CVS (CVS) to reflect headwinds from rebate guarantees and Aetna’s (AET) large group rated business. He believes the pressure on the shares due to rebate guarantees is overdone in that it represents less than 2% of its revenues. Ryhee reiterated his Outperform rating and $103 price target on CVS shares.
https://thefly.com/landingPageNews.php?id=2848313
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.